LFST

LifeStance Health Group, Inc.
$12.37
-0.15 (-1.20%)
Mkt Cap 4.75B
Volume 3,533,542
52W Range 4.77-13.56
Sector Healthcare
Beta 1.24
EPS (TTM) 0.13 USD
P/E Ratio 95.38
Revenue (TTM) 1.58B USD
Rev Growth (5Y) +30.4%
EPS Growth (5Y) +12.0%
AlphaVal · Fair Value
What we estimate one share is worth
$7.70
Overvalued strong signal
61.3% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade · Gated
How strong & durable the business is
F
Platform & Compounding FCF
30.0 / 100 pillar composite (overridden)
A platform business that compounds free cash flow — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019
Revenue 1.42B 1.25B 1.06B 859.54M 667.51M 377.22M 212.52M
Net Income 9.66M (57.44M) (186.26M) (215.56M) (307.20M) (38.07M) 5.67M
EPS 0.03 -0.15 -0.51 -0.61 -1.05 -0.83 -0.16
Free Cash Flow 110.03M 85.69M (57.40M) (26.47M) (85.07M) (46.60M) 2.73M
FCF / Share 0.29 0.23 -0.16 -0.07 -0.26 -0.12 0.01
Operating CF 146.15M 107.26M (16.88M) 52.79M 9.42M (8.53M) 17.05M
Total Assets 2.20B 2.12B 2.11B 2.17B 1.93B 1.57B 280.78M
Total Debt 194.10M 485.19M 511.04M 478.83M 158.74M 366.27M 79.31M
Cash & Equiv 248.64M 154.57M 78.82M 108.62M 148.03M 18.83M 3.48M
Book Value 1.52B 1.45B 1.43B 1.52B 1.55B 997.84M (166.35M)
Return on Equity 0.01 -0.04 -0.13 -0.14 -0.20 -0.04 N/A
LFST News
Take the Zacks Approach to Beat the Markets: HF Sinclair, Accenture & FirstCash in Focus
Oct 12, 2026 07:11 AM · zacks.com
Nearly Half of Americans Say Fear of an Unwanted Viral Moment Keeps Them from Being Themselves in Public, LifeStance Survey Finds
Sep 30, 2026 05:00 AM · prnewswire.com
LifeStance Health CTO Sells 42,067 Shares for $541,402
Sep 23, 2026 02:55 AM · fool.com
74,169 Shares in LifeStance Health Group, Inc. $LFST Bought by HighTower Advisors LLC
Sep 16, 2026 12:37 AM · defenseworld.net
LifeStance Health Group, Inc. (LFST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Sep 15, 2026 08:21 AM · seekingalpha.com
Analyzing Mangoceuticals (NASDAQ:MGRX) and LifeStance Health Group (NASDAQ:LFST)
Sep 10, 2026 11:45 PM · defenseworld.net
Here's Why LifeStance Health Group (LFST) is a Great Momentum Stock to Buy
Sep 10, 2026 09:01 AM · zacks.com
5 Low-Leverage Stocks to Buy Amid Rising Oil Prices & Inflation Woes
Sep 10, 2026 07:45 AM · zacks.com
LifeStance Health Group Announces Pricing of Secondary Public Offering
Sep 09, 2026 05:15 AM · globenewswire.com
LifeStance Health Group Announces Launch of Secondary Public Offering
Sep 09, 2026 03:00 AM · globenewswire.com